These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Choice of cholesterol-lowering drugs. Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601 [No Abstract] [Full Text] [Related]
44. The acceptability of resin therapy to patients attending a hospital lipid clinic. Iversen SA; Davidson D; Davidson C Br J Clin Pharmacol; 1995 Jul; 40(1):92-4. PubMed ID: 8527276 [TBL] [Abstract][Full Text] [Related]
45. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III. JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027 [TBL] [Abstract][Full Text] [Related]
46. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
47. [The cholesterol question. Disinformed information]. Bobbio M; Brusca A G Ital Cardiol; 1991 Sep; 21(9):1029-33. PubMed ID: 1790828 [No Abstract] [Full Text] [Related]
48. Effects of a phenolic ether, Su-13437, on serum cholesterol, triglyceride, and transaminase levels of human subjects. Duncan CH; Best MM Circulation; 1970 Nov; 42(5):859-65. PubMed ID: 5477258 [No Abstract] [Full Text] [Related]
50. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia. Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769 [TBL] [Abstract][Full Text] [Related]
51. Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee. Henry DA; Cully LR; Grigson T; Lee C Med J Aust; 1991 Sep; 155(5):332-6. PubMed ID: 1895979 [TBL] [Abstract][Full Text] [Related]
53. Lack of cholesterol-lowering effect of graded doses of cholestyramine in children with Alagille syndrome: a pilot study. Larrosa-Haro A; Sáenz-Rivera C; González-Ortiz M; Coello-Ramírez P; Vázquez-Camacho G J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):50-3. PubMed ID: 12499996 [TBL] [Abstract][Full Text] [Related]
54. Effect of cholestyramine on tissue pools of cholesterol a preliminary report. Kudchodkar BJ; Sodhi HS; Horlick L; Nazir DJ Proc Soc Exp Biol Med; 1975 Feb; 148(2):393-6. PubMed ID: 1121487 [TBL] [Abstract][Full Text] [Related]
55. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia. Denke MA; Grundy SM Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022 [TBL] [Abstract][Full Text] [Related]
56. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia. Deslypere JP Acta Cardiol; 1989; 44(5):379-88. PubMed ID: 2690545 [TBL] [Abstract][Full Text] [Related]
57. [Atherosclerosis. Its implications, prevention and dietetic and pharmacological treatment]. Sangiorgi M; Martinelli M Minerva Med; 1978 Dec; 69(61):4227-33. PubMed ID: 733078 [No Abstract] [Full Text] [Related]